Soo S. Ko

Inhibition of Clinically Relevant Mutant Variants of HIV-1 by Quinazolinone Non-Nucleoside Reverse Transcriptase Inhibitors

Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers et al. · Journal of Medicinal Chemistry · 2000 · 301 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Stereocontrolled synthesis of D-pentitols, 2-amino-2-deoxy-D-pentitols and 2-deoxy-D-pentitols from D-glyceraldehyde acetonide

N. MINAMI, Soo S. Ko, Yoshito Kishi · Journal of the American Chemical Society · 1982 · 224 citations

Natural Sciences, Biochemistry, Chemistry +5

The increase in intracellular free calcium associated with IgG gamma 2b/gamma 1 Fc receptor-ligand interactions: role in phagocytosis.

John Ding‐E Young, Soo S. Ko, Z A Cohn · Proceedings of the National Academy of Sciences · 1984 · 156 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Lanosterol 14 alpha-methyl demethylase. Isolation and characterization of the third metabolically generated oxidative demethylation intermediate.

Robert T. Fischer, J M Trzaskos, Ronald L. Magolda et al. · Journal of Biological Chemistry · 1991 · 120 citations · Full text

Life Sciences, Biochemistry, Enzymology +8

Expanded-Spectrum Nonnucleoside Reverse Transcriptase Inhibitors Inhibit Clinically Relevant Mutant Variants of Human Immunodeficiency Virus Type 1

Jeffrey W. Corbett, Soo S. Ko, James D. Rodgers et al. · Antimicrobial Agents and Chemotherapy · 1999 · 119 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17